<DOC>
	<DOCNO>NCT00537251</DOCNO>
	<brief_summary>To compare efficacy ( term metabolic control evaluate HbA1c level ) treatment insulin glargine basal insulin insulin analogue ( insulin lispro ) mealtime insulin regimen insulin NPH basal insulin regular insulin , mealtime insulin , 16 week treatment phase regimen compare safety treatment , evaluate hypoglycemic rate .</brief_summary>
	<brief_title>32 Week , Open , Randomized , 2 Way Cross Over Multicentre Trial Compare Safety &amp; Efficacy Combination HOE901 Insulin Analogue Once Daily Bedtime + Lispro Insulin Before Meals vs NPH Insulin ( Twice Day ) + Regular Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Multicenter , open-label , randomize ( allocation ratio 1:1 ) , cross-over two treatment phase 16 week two treatment group : - Study arm insulin glargine + insulin lispro ( phase 1 ) insulin NPH + regular insulin ( phase 2 ) - Insulin NPH + regular insulin ( phase 1 ) insulin glargine + insulin lispro ( phase 2 )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Subjects type 1 diabetes mellitus 1865 year age CPeptide negative Treated least 6 month multiple daily dos insulin HbA1c great equal 7.0 % less equal 9.5 % BMI le equal 35 kg/mÂ² . Women childbearing potential must negative pregnancy test visit 1 must use effective contraceptive method study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>